Home/Filings/4/0001209191-22-003526
4//SEC Filing

Menichella Daniel L 4

Accession 0001209191-22-003526

CIK 0001751299other

Filed

Jan 17, 7:00 PM ET

Accepted

Jan 18, 5:09 PM ET

Size

7.9 KB

Accession

0001209191-22-003526

Insider Transaction Report

Form 4
Period: 2022-01-14
Menichella Daniel L
DirectorChief Executive Officer
Transactions
  • Award

    Restricted Stock Units

    2022-01-14+70,20070,200 total
    Common Stock (70,200 underlying)
  • Award

    Restricted Stock Units

    2022-01-14+250,000250,000 total
    Common Stock (250,000 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
  • [F2]The restricted stock units shall vest 100% on April 30, 2022 provided, however, that the grant shall immediately vest as of the date of any change in control of the issuer.
  • [F3]The restricted stock units shall vest on the earlier of 50% on January 14, 2023 and 50% on January 14, 2024 provided, however, that the grant shall immediately vest as of the date of any change in control of the issuer.

Issuer

Kaleido Biosciences, Inc.

CIK 0001751299

Entity typeother

Related Parties

1
  • filerCIK 0001472131

Filing Metadata

Form type
4
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 5:09 PM ET
Size
7.9 KB